Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 49,400
- Avg volume
- 50,314
- Day's range
- $0.02 – $0.02
- Shares out
- —
- Stochastic %K
- 0%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It also engages in exploration of Colchester East Natural Hydrogen Project comprising of 2,104 c...
Show more
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It also engages in exploration of Colchester East Natural Hydrogen Project comprising of 2,104 claims located within the Cumberland Basin in Nova Scotia; and the Timiskaming District of northern Ontario. It has a collaboration agreement with EIREX for the development and commercialization of EIREX's novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.
- Industry
- Health Information Services
- Sector
- Healthcare
- Website
- https://www.diagnamed.com
- Address
- 82 Richmond Street East, Toronto, Canada
Latest news
No headlines yet.
